Navigation Links
Ikaria to Present at 26th Annual JPMorgan Healthcare Conference
Date:1/3/2008

CLINTON, N.J., Jan. 3 /PRNewswire/ -- Ikaria Holdings, Inc., a fully integrated critical care biopharmaceutical company, announced today that its Chairman & CEO, David Shaw, will present at the 26th Annual JPMorgan Healthcare Conference on Tuesday, January 8, 2008 at 3:00 p.m., PST. The conference will be held January 7-10 at The Westin St. Francis Hotel in San Francisco.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a fully integrated biotherapeutics company focused on the development and commercialization of innovative in-hospital pharmaceutical products and drug/device combinations for the critically ill. The company's product, INOmax(R) (nitric oxide) for inhalation, is an FDA- approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns. The drug also is approved by regulatory authorities and used in Canada, Europe, Australia and Latin America. In addition to marketing and selling its INOmax product, Ikaria is engaged in both Phase II trials with Covox(R) (carbon monoxide) for inhalation and Phase I trials with hydrogen sulfide (H2S) for various indications. Ikaria has a staff of over 300 people and is headquartered in Clinton, NJ, with research facilities in Seattle, WA and Madison, WI and manufacturing in Port Allen, LA. For more information on Ikaria, please visit http://www.ikaria.com.

CONTACTS

Matthew Bennett

Ikaria

908-238-6673

matthew.bennett@ikaria.com

Elizabeth Scott

The Ruth Group

646-536-7014

escott@theruthgroup.com


'/>"/>
SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Ikaria Founding Scientist Named 2007 MacArthur Fellow
2. New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces
3. Thoratec Presentation at JP Morgan Conference to be Webcast
4. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference
5. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
6. CryoLife to Present at OneMedPlace Finance Forum
7. Exelixis Announces January 10 Webcast of Presentation at the 26th Annual JPMorgan Healthcare Conference
8. Onyx Pharmaceuticals to Present at JPMorgan Healthcare Conference
9. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. Thermo Fisher Scientific to Present at the 26th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... ... August 15, 2017 , ... Any expert in stem ... compromised these disciplines for more than half a century. Despite their essential roles ... It is widely known that molecular tags developed for this purpose also tag other, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Coffea arabica accounts ... and abiotic factors. During this educational webinar, participants will learn about the importance ... gain a better understanding of how genomics is important for coffee breeding improvement. ...
(Date:8/14/2017)... Oregon (PRWEB) , ... August 14, 2017 , ... ... that provide essential device-to-computer interconnect using USB or PCI Express, announced the release ... , SYZYGY is intended to satisfy the need for a compact, low cost, ...
(Date:8/11/2017)... Antonio, Texas (PRWEB) , ... August 11, 2017 , ... ... a rebranding campaign this month that will incorporate important key elements including a new ... thank the community that has supported them, Bill Miller has partnered with the South ...
Breaking Biology Technology:
(Date:6/14/2017)... PARIS , June 15, 2017  IBM (NYSE: IBM ... the international tech event dedicated to developing collaboration between startups ... on June 15-17. During the event, nine startups will ... deliver value in various industries. ... in the international market, with a 30 percent increase in ...
(Date:4/24/2017)... , April 24, 2017 ... and partner with  Identity Strategy Partners, LLP (IdSP) ... "With or without President Trump,s March 6, 2017 ... Terrorist Entry , refugee vetting can be instilled with ... resettlement. (Right now, all refugee applications are suspended ...
(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):